VPIM
GHSI

Vanguard Personalized Indexing Management’s Guardion Health Sciences, Inc. Common Stock GHSI Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio GHSI Stock Details GHSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-599
Closed -$4K – 1321
2022
Q2 		$4K Buy
+599
New +$5.24K ﹤0.01% 1257

Other funds holding GHSI

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Personalized Indexing Management's GHSI Position: Q3 2022 in Review

Vanguard Personalized Indexing Management sold out of Guardion Health Sciences, Inc. Common Stock (GHSI) in Q3 2022, closing a stake of 599 shares — an estimated $4K sold.

Vanguard Personalized Indexing Management first reported a position in GHSI in Q2 2022 and held it in 1 quarter. The position peaked at $4K in Q2 2022. 23 funds tracked by Wall St. Rank hold GHSI as of Q3 2022.

  • Vanguard Personalized Indexing Management reported no remaining Guardion Health Sciences, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Vanguard Personalized Indexing Management sold 599 Guardion Health Sciences, Inc. Common Stock shares in Q3 2022, an estimated $4K.
  • Vanguard Personalized Indexing Management first reported a position in Guardion Health Sciences, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
  • Vanguard Personalized Indexing Management's Guardion Health Sciences, Inc. Common Stock position peaked at $4K in Q2 2022.
  • 23 funds tracked by Wall St. Rank held Guardion Health Sciences, Inc. Common Stock as of Q3 2022.

Based on Vanguard Personalized Indexing Management's 13F filing for Q3 2022, filed 14 Nov 2022.